Home - Lustgarten Foundation: Pancreatic Cancer Research
LustGarden Foundation for Pancreatic Cancer Research

Pancreatic Cancer Research

As the largest private funder of pancreatic cancer research, we are relentlessly focused on improving patient outcomes and we are making progress every day. Thanks to separate funding to support administrative expenses, 100 percent of every donation goes directly to research.

Navigating Pancreatic Cancer

We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.

Patient Checklist

Checklist

August 1, 2018 ladmin
As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]
Lets Win! Pancreatic Cancer

Let’s Win! Pancreatic Cancer

July 20, 2018 ladmin
LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]

Pancreatic Cancer Connections

July 7, 2018 ladmin
Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery. Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.

Lustgarten News

View All Articles

Juneteenth Webinar:
Meet Dr. Posey

Pancreatic cancer is a uniquely challenging disease, requiring bold and innovative science. We know these challenges are even greater for Black people and African Americans, who experience both higher incidence and death rates than other populations.
Avery D. Posey, PhD, knows the statistic well–both as an African American scientist and a patient family member. Dr. Posey is the inaugural recipient of the Lustgarten Foundation Career Development Grant honoring Congressman John R. Lewis. He will discuss the importance of diversity within the field of pancreatic cancer research and the need for more BIPOCx participants in clinical trials. Made possible in part through the support of Bristol Myers Squibb, this Juneteenth webinar is part of the Lustgarten Foundation’s recognition of National Black Family Cancer Awareness Week June 17-23. Created by the U.S. Food & Drug Administration’s Oncology Center of Excellence, Black Family Cancer Week is designed to increase cancer awareness in one of the most vulnerable segments of the US population. #BlackFamCan This webinar is made possible in part through the support of Bristol Myers Squibb.

Learn More

In Person Walks
Are Back!

Join Hundreds of Walkers and Runners Across New York on June 27th  in the Critical Fight Against Pancreatic Cancer. The Lustgarten Foundation’s New York Walk Series is your chance to join forces with hundreds of others whose lives have been touched by pancreatic cancer. Together we will raise the critical funds and awareness needed to defeat this this devastating disease. Register. Donate. Fundraise. Walk where you want, when you want in your neighborhood. 100% of all donations fund lifesaving pancreatic cancer research. Whether you walk with us in New York City or walk in your own neighborhood, your action will change lives and inspire others! Choose an event near you and join our community of patients, survivors and loved ones coming together to celebrate, reflect and remember as we move closer to a cure for pancreatic cancer. Your Walk for Research will leave you energized and optimistic about the future. Together, we will defeat this disease!

Learn More

Register For Lustgarten Live!

Welcome to LustgartenLIVE! a new quarterly series of webinars designed to bring you face-to-face with the best researchers investigating pancreatic cancer. Moderated by Andrew Rakeman, PhD , Vice President of Research, each webinar in the series will focus on a different aspect of the research funded through your donations. Hope is on the horizon! REGISTRATION IS NOW OPEN for Personalized Medicine: Transforming Treatment
Personalized medicine is an important and evolving research area for pancreatic cancer. By identifying patients’ own genetic and tumor make-up, as well as their specific mutations, physicians can create custom treatment strategies unique to each patient’s needs. Lustgarten-funded research is exploring various approaches and technologies for the most effective way to personalize medicine, including replicating 3D tumor cells in the lab to create organoids.

Learn More

Pancreatic Cancer News

View All Articles

‘Bad fat’ suppresses killer T cells from attacking cancer

10. 6. 21 ladmin
LA JOLLA–(June 10, 2021) In order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized “killer” T cells. Salk researchers led by Professor Susan Kaech have found that the environment inside tumors (the tumor microenvironment) contains an abundance of oxidized fat molecules, which, when ingested by the […]

Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer

24. 5. 21 ladmin
For decades, KRAS interactors have been sought after as potential therapeutic targets in KRAS mutant cancers, especially pancreatic ductal adenocarcinoma (PDAC). Our proximity labeling screen with KRAS in PDAC cells highlights RSK1 as a notable mutant-specific interactor. Functionally, we show that RSK1 mediates negative feedback on wild-type (WT) KRAS in PDAC cells. Targeting oncogenic KRAS […]

Predicting chemotherapy response and tailoring treatments for pancreatic cancer patients

24. 5. 21 ladmin
By 2030, pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer, is projected to become the second leading cause of cancer-related deaths in the United States. Not only are therapeutic options limited, but nearly half of all PDAC patients who have their tumors removed surgically experience disease recurrence within a year, despite receiving […]

New research optimizes body’s own immune system to fight cancer

14. 5. 21 ladmin
A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient’s own immune system to fight tumors. The research could improve cancer therapies in the future for millions of people worldwide. The […]

Pancreatic cancer trials fail to include minorities despite worse outcomes

14. 5. 21 ladmin
Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age and die sooner, clinical trials fail to include representative proportions of non-White patients at every phase of study, according to research that was selected for presentation at Digestive Disease Week® (DDW) 2021. “We see disparities […]

Gene-Targeted Drug Shows Promise Against a Form of Pancreatic Cancer

11. 5. 21 ladmin
There may be new hope for patients with a subset of pancreatic cancers tied to certain genetic mutations, a new study finds. The study involving 42 patients found that a “PARP inhibitor” drug called rucaparib (Rubraca), may replace chemotherapy in the up to 8% of pancreatic cancer patients whose tumors are marked by BRCA1, BRCA2 […]

Hopkins-Led Research Team Takes Gene Mutation Detection in Blood to the Next Level

4. 5. 21 ladmin
Next-generation gene sequencing (NGS) technologies —in which millions of DNA molecules are simultaneously but individually analyzed— theoretically provides researchers and clinicians the ability to noninvasively identify mutations in the blood stream. Identifying such mutations enables earlier diagnosis of cancer and can inform treatment decisions. Johns Hopkins Kimmel Cancer Center researchers developed a new technology to overcome the […]

Positive Thinking Is Powerful During and After Cancer Treatment

29. 4. 21 ladmin
In the fall of 2018, Teri Cettina began feeling a mysterious pain around her ribs. “I thought I had done too many ab exercises at the gym,” says the 55-year-old health writer from Portland, Oregon. When Cettina visited her doctor, her blood and urine tests came back normal. But over the next several weeks, the […]

Join Us

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top